Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

The red cell distribution width as a prognostic indicator in idiopathic pulmonary fibrosis.

Nathan SD, Reffett T, Brown AW, Fischer CP, Shlobin OA, Ahmad S, Weir N, Sheridan MJ.

Chest. 2013 Jun;143(6):1692-8. doi: 10.1378/chest.12-1368.

PMID:
23238641
2.

Prognostic value of red cell distribution width in patients with sarcoidosis.

Ozsu S, Ozcelik N, Oztuna F, Ozlu T.

Clin Respir J. 2015 Jan;9(1):34-8. doi: 10.1111/crj.12101. Epub 2014 Feb 17.

PMID:
24405971
3.

Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.

Song JW, Do KH, Jang SJ, Colby TV, Han S, Kim DS.

Chest. 2013 May;143(5):1422-9. doi: 10.1378/chest.11-2735.

PMID:
23715088
4.

Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis.

Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O'Byrne PM, Strieter RM, Kolb M.

Am J Respir Crit Care Med. 2009 Apr 1;179(7):588-94. doi: 10.1164/rccm.200810-1534OC. Epub 2009 Jan 16.

PMID:
19151190
5.

Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension.

Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ.

Am J Cardiol. 2009 Sep 15;104(6):868-72. doi: 10.1016/j.amjcard.2009.05.016.

PMID:
19733726
6.

Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.

Alhamad EH, Masood M, Shaik SA, Arafah M.

Clin Respir J. 2008 Oct;2(4):220-6. doi: 10.1111/j.1752-699X.2008.00070.x.

PMID:
20298338
7.

C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.

Vuga LJ, Tedrow JR, Pandit KV, Tan J, Kass DJ, Xue J, Chandra D, Leader JK, Gibson KF, Kaminski N, Sciurba FC, Duncan SR.

Am J Respir Crit Care Med. 2014 Apr 15;189(8):966-74. doi: 10.1164/rccm.201309-1592OC.

8.

Red blood cell distribution width predicts responsiveness of acute pulmonary vasodilator testing in patients with idiopathic pulmonary arterial hypertension.

Xi Q, Liu Z, Zhao Z, Luo Q.

Clin Chim Acta. 2015 Jun 15;446:272-6. doi: 10.1016/j.cca.2015.04.041. Epub 2015 May 9.

PMID:
25966828
9.

Red blood cell distribution width is a significant prognostic marker in advanced heart failure, independent of hemoglobin levels.

Tseliou E, Terrovitis JV, Kaldara EE, Ntalianis AS, Repasos E, Katsaros L, Margari ZJ, Matsouka C, Toumanidis S, Nanas SN, Nanas JN.

Hellenic J Cardiol. 2014 Nov-Dec;55(6):457-61.

10.

Incremental predictive value of red cell distribution width for 12-month clinical outcome after acute myocardial infarction.

Lee JH, Yang DH, Jang SY, Choi WS, Kim KH, Lee WK, Bae MH, Park HS, Cho Y, Chae SC.

Clin Cardiol. 2013 Jun;36(6):336-41. doi: 10.1002/clc.22114. Epub 2013 Apr 8.

11.

The relationship between red blood cell distribution width and the clinical outcomes in non-ST elevation myocardial infarction and unstable angina pectoris: a 3-year follow-up.

Gul M, Uyarel H, Ergelen M, Karacimen D, Ugur M, Turer A, Bozbay M, Ayhan E, Akgul O, Uslu N.

Coron Artery Dis. 2012 Aug;23(5):330-6. doi: 10.1097/MCA.0b013e3283564986.

PMID:
22735091
12.

Red blood cell distribution width as a prognostic marker of mortality in patients on chronic dialysis: a single center, prospective longitudinal study.

Sičaja M, Pehar M, Đerek L, Starčević B, Vuletić V, Romić Ž, Božikov V.

Croat Med J. 2013 Feb;54(1):25-32.

13.

An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock.

Kim CH, Park JT, Kim EJ, Han JH, Han JS, Choi JY, Han SH, Yoo TH, Kim YS, Kang SW, Oh HJ.

Crit Care. 2013 Dec 9;17(6):R282. doi: 10.1186/cc13145.

14.

Progressive rise in red cell distribution width is associated with disease progression in ambulatory patients with chronic heart failure.

Cauthen CA, Tong W, Jain A, Tang WH.

J Card Fail. 2012 Feb;18(2):146-52. doi: 10.1016/j.cardfail.2011.10.013. Epub 2011 Dec 3.

15.

Clinical usefulness of measuring red blood cell distribution width in patients with systemic sclerosis.

Farkas N, Szabó A, Lóránd V, Sarlós DP, Minier T, Prohászka Z, Czirják L, Varjú C.

Rheumatology (Oxford). 2014 Aug;53(8):1439-45. doi: 10.1093/rheumatology/keu022. Epub 2014 Mar 21.

PMID:
24659752
16.

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.

Jenkins RG, Simpson JK, Saini G, Bentley JH, Russell AM, Braybrooke R, Molyneaux PL, McKeever TM, Wells AU, Flynn A, Hubbard RB, Leeming DJ, Marshall RP, Karsdal MA, Lukey PT, Maher TM.

Lancet Respir Med. 2015 Jun;3(6):462-72. doi: 10.1016/S2213-2600(15)00048-X. Epub 2015 Mar 12.

PMID:
25770676
17.

Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis.

Prasse A, Probst C, Bargagli E, Zissel G, Toews GB, Flaherty KR, Olschewski M, Rottoli P, Müller-Quernheim J.

Am J Respir Crit Care Med. 2009 Apr 15;179(8):717-23. doi: 10.1164/rccm.200808-1201OC. Epub 2009 Jan 29.

PMID:
19179488
18.

Red blood cell distribution width predicts survival in patients with Eisenmenger syndrome.

Yang T, Sun YJ, Xiong CM, Zeng WJ, Ni XH, Zhao ZH, Liu ZH, Gu Q, He JG.

Clin Chem Lab Med. 2014 May;52(5):743-50. doi: 10.1515/cclm-2013-0747.

PMID:
24317786
19.

Association between Red Cell Distribution Width and Mortality after Cardiac Resynchronization Therapy.

Topaz G, Haim M, Kusniec J, Kazum S, Goldenberg G, Golovchiner G, Kornowski R, Strasberg B, Eisen A.

Isr Med Assoc J. 2015 Aug;17(8):505-9.

20.

Change in serum marker of oxidative stress in the progression of idiopathic pulmonary fibrosis.

Matsuzawa Y, Kawashima T, Kuwabara R, Hayakawa S, Irie T, Yoshida T, Rikitake H, Wakabayashi T, Okada N, Kawashima K, Suzuki Y, Shirai K.

Pulm Pharmacol Ther. 2015 Jun;32:1-6. doi: 10.1016/j.pupt.2015.03.005. Epub 2015 Apr 9.

Supplemental Content

Support Center